←
Linksbridge SPC951 posts
Linksbridge SPC avatar

Linksbridge SPC

@linksbridge

Linksbridge expands the capacity of NGOs, IGOs, and nonprofits to improve human lives.

◷ Joined January 2010▧ 297 Photos and videos
Linksbridge SPC avatar
Linksbridge SPC@linksbridge·7 Feb 2025

Linksbridge will no longer post updates on this platform. We invite you to follow us on LinkedIn or Bluesky. Visit our website for more. ✌🏽

Linksbridge SPC avatar
Linksbridge SPC@linksbridge·6 Feb 2025

Just four days after an Ebola outbreak was declared in Uganda, a trial to evaluate a vaccine against the disease has begun. This week's highlights explore the rapid launch of the study and more. linkedin.com/pulse/linksbrid…

Linksbridge SPC avatar
Linksbridge SPC@linksbridge·30 Jan 2025

Essential medicines remain unavailable and unaffordable for a large portion of the world—an "important violation of human rights" that requires urgent, comprehensive action—according to a new analysis out this month. linkedin.com/pulse/linksbrid…

Linksbridge SPC avatar
Linksbridge SPC@linksbridge·17 Jan 2025

Since 2019, Linksbridge has tracked over 180 planned integrated campaign deliveries—including Madagascar's polio/measles vaccination effort. Linksbridge's Campaigns Hub provides health campaign data for over 20 interventions. Access it here: bit.ly/4gSTo1E

Madagascar successfully vaccinated millions of children against polio & measles this fall, protecting them from the devastating, preventable diseases. Through integrated efforts such as these, a healthier, polio-free world is #HumanlyPossible. Learn more: adobe.ly/3P6R1fB

Linksbridge SPC avatar
Linksbridge SPC@linksbridge·16 Jan 2025

Regional manufacturing efforts got a boost in recent days via two initiatives aiming to drive local PCV production. More on these initiatives and other pharma news important to global health in this week’s highlights. linkedin.com/pulse/linksbrid…

Linksbridge SPC avatar
Linksbridge SPC@linksbridge·15 Jan 2025

In 2022, Linksbridge collaborated with the Gates Foundation and other stakeholders to create materials in support of the market entry and scale-up of Wolbachia replacement technology. The forecast's methods and results are available as global public goods: bit.ly/4aioDAQ

The @WMPglobal has helped protect more than 11 million people in 14 countries from diseases like dengue. How? By growing millions of mosquitoes. @ScottLOneill, the programme’s founder, explains how their method works in ‘Behind the Research’ ⤵️ linkedin.com/pulse/millions-…

Linksbridge SPC avatar
Linksbridge SPC@linksbridge·13 Jan 2025

Nigeria has launched its first malaria vaccination campaign for children. More on this effort and campaigns across Africa, Asia, and Latin America in our latest health campaigns roundup. linkedin.com/pulse/health-ca…

Linksbridge SPC avatar
Linksbridge SPC@linksbridge·19 Dec 2024

Our last issue of 2024 covers a little bit of everything. We highlight mpox vaccine manufacturing, promising Phase 2b results for a blood-stage malaria vaccine, news from Institut Pasteur de Dakar's centenary celebration, and more. linkedin.com/pulse/linksbrid…

Linksbridge SPC avatar
Linksbridge SPC@linksbridge·12 Dec 2024

WHO has granted prequalification to the first test for TB diagnosis and antibiotic susceptibility testing. In this week's highlights, we explore this critical milestone, the first regulatory nod for moxidectin in a river blindness-endemic country, and more.linkedin.com/pulse/linksbrid…

Linksbridge SPC avatar
Linksbridge SPC@linksbridge·9 Dec 2024

In this month's roundup of campaign news, we highlight polio and cholera outbreak response efforts, integrated campaigns delivering vaccines, vitamin A supplements and deworming treatments, and HPV campaigns targeting children in Africa and Asia. linkedin.com/pulse/health-ca…

Linksbridge SPC avatar
Linksbridge SPC@linksbridge·5 Dec 2024

This week’s highlights explore promising clinical trial results for a novel TB regimen, Unitaid’s pledge to accelerate access to HIV PrEP drug lenacapavir, funds for global health vaccine R&D, developments in the African manufacturing space, and more. linkedin.com/pulse/linksbrid…

Linksbridge SPC avatar
Linksbridge SPC@linksbridge·28 Nov 2024

Drug and vaccine R&D investments were front and center in this week's highlights. Dyadic won backing for malaria and RSV mAbs development, Insud scored funds for a postpartum hemorrhage treatment trial in LMICs, and more. linkedin.com/pulse/linksbrid…

Linksbridge SPC avatar
Linksbridge SPC@linksbridge·21 Nov 2024

Novartis dethroned eight-time-front-runner GSK in the 2024 Access to Medicine Index. In this week’s highlights, we dive into AtM's ranking of leading pharma companies’ efforts to provide access to their products in LMICs and more. linkedin.com/pulse/linksbrid…

Linksbridge SPC avatar
Linksbridge SPC@linksbridge·14 Nov 2024

New trials for mpox countermeasures are in the works. Catch up on these developments and other news related to H5N1, HIV, TB and TCV in this week's highlights. linkedin.com/pulse/linksbrid…